Literature DB >> 12765941

Glucose 6-phosphate regulates hepatic glycogenolysis through inactivation of phosphorylase.

Susan Aiston1, Birgitte Andersen, Loranne Agius.   

Abstract

High glucose concentration suppresses hepatic glycogenolysis by allosteric inhibition and dephosphorylation (inactivation) of phosphorylase-a. The latter effect is attributed to a direct effect of glucose on the conformation of phosphorylase-a. Although glucose-6-phosphate (G6P), like glucose, stimulates dephosphorylation of phosphorylase-a by phosphorylase phosphatase, its physiological role in regulating glycogenolysis in intact hepatocytes has not been tested. We show in this study that metabolic conditions associated with an increase in G6P, including glucokinase overexpression and incubation with octanoate or dihydroxyacetone, cause inactivation of phosphorylase. The latter conditions also inhibit glycogenolysis. The activity of phosphorylase-a correlated inversely with the G6P concentration within the physiological range. The inhibition of glycogenolysis and inactivation of phosphorylase-a caused by 10 mmol/l glucose can be at least in part counteracted by inhibition of glucokinase with 5-thioglucose, which lowers G6P. In conclusion, metabolic conditions that alter the hepatic G6P content affect glycogen metabolism not only through regulation of glycogen synthase but also through regulation of the activation state of phosphorylase. Dysregulation of G6P in diabetes by changes in activity of glucokinase or glucose 6-phosphatase may be a contributing factor to impaired suppression of glycogenolysis by hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12765941     DOI: 10.2337/diabetes.52.6.1333

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

2.  An enzymatic colorimetric assay for glucose-6-phosphate.

Authors:  Aiping Zhu; Roberto Romero; Howard R Petty
Journal:  Anal Biochem       Date:  2011-08-27       Impact factor: 3.365

3.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

4.  Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.

Authors:  L J Hampson; P Mackin; L Agius
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

Review 5.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

6.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

7.  The aqueous extract of Withania coagulans fruit partially reverses nicotinamide/streptozotocin-induced diabetes mellitus in rats.

Authors:  Kirtikar Shukla; Piyush Dikshit; Rimi Shukla; Jasvinder K Gambhir
Journal:  J Med Food       Date:  2012-06-25       Impact factor: 2.786

8.  Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.

Authors:  Sara Abbadi; Julio J Rodarte; Ameer Abutaleb; Emily Lavell; Chris L Smith; William Ruff; Jennifer Schiller; Alessandro Olivi; Andre Levchenko; Hugo Guerrero-Cazares; Alfredo Quinones-Hinojosa
Journal:  Mol Cancer Res       Date:  2014-07-07       Impact factor: 5.852

9.  Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis.

Authors:  Yongxian Zhang; Daqian Xu; Heng Huang; Susie Chen; Lingdi Wang; Lu Zhu; Xiaomeng Jiang; Xiangbo Ruan; Xiaolin Luo; Peijuan Cao; Weizhong Liu; Yi Pan; Zhenzhen Wang; Yan Chen
Journal:  Mol Endocrinol       Date:  2013-01-01

10.  An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Authors:  S M Poucher; S Freeman; S J G Loxham; G Convey; J B Bartlett; J De Schoolmeester; J Teague; M Walker; A V Turnbull; A D Charles; F Carey; S Berg
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.